Sharekhan

Dr Agarwals Health Care Ltd

Fri 20/02/2026,15:54:57 NSE: AGARWALEYE

₹ 445.90 -4.80 (-1.07%)
BUY NOW Buy Dr Agarwals Health Care Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Dr Agarwals Health Care Ltd

Fri 20/02/2026,16:1:0

Dr Agarwals Health Care Ltd

Fri 20/02/2026,15:54:57 | NSE : AGARWALEYE

₹ 445.90-4.80 (-1.07%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 451.80

Previous Close

₹ 450.70

Volume

50625

Mkt Cap ( Rs. Cr)

₹14126.45

High

₹ 451.80

Low

₹ 442.95

52 Week High

₹ 568.00

52 Week Low

₹ 327.00

Book Value Per Share

₹ 60.95

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Dr Agarwals Health Care Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

445.90

26

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

26

Option Chain

Analyzes market sentiment, predicts Dr Agarwals Health Care Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dr. Agarwals Health - Amalgamation/Merger

    17 Feb 2026, 1:27PM Receipt of Observation Letter with no adverse observations / no objection from the Stock Exchanges in relation to the Scheme of amalgamation betwe

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

    17 Feb 2026, 1:31PM Receipt of observation letters conveying 'no adverse observations' / 'no objection' from the Stock Exchanges in relation to the Scheme of amalgamation

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Feb 2026, 4:20PM Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Feb 2026, 4:18PM Intimation of Schedule of Analyst / Investors Meet, is attached.

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Feb 2026, 2:55PM Dr. Agarwal's Health Care Limited has informed the Exchange about Transcript

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    10 Feb 2026, 3:00PM Transcript of the Discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and nine months ended

  • Dr. Agarwals Health - Disclosure under SEBI Takeover Regulations

    6 Feb 2026, 7:50PM Dr. Athiya Agarwalÿhas Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substanti

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Feb 2026, 3:02PM Dr. Agarwal's Health Care Limited has informed the Exchange about Link of Recording

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    4 Feb 2026, 3:08PM Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Co

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Investor Presentation

    3 Feb 2026, 9:27PM Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and nine months ended December 31, 2025, is

  • Dr. Agarwals Health - Investor Presentation

    3 Feb 2026, 9:25PM Dr. Agarwal's Health Care Limited has informed the Exchange about Investor Presentation

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    3 Feb 2026, 8:16PM Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended December 31, 2025, is attached.

  • Dr. Agarwals Health - Monitoring Agency Report

    3 Feb 2026, 8:14PM Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended December 31, 2025.

  • Dr. Agarwals Health - Options to purchase securities

    3 Feb 2026, 8:07PM Dr. Agarwal's Health Care Limited has informed the Exchange about Options to purchase securities

  • Dr. Agarwals Health - Grant Of Options Under Dr. Agarwal'S Health Care Limited - Employees Stock Option Scheme 2022

    3 Feb 2026, 8:06PM Intimation of Grant of Options under Dr. Agarwal's Health Care Limited - Employees Stock Option Scheme 2022 is attached.

  • Dr. Agarwals Health Q3 net profit jumps 84.51% at Rs 14.06 cr

    3 Feb 2026, 8:00PM The company reported standalone net profit of Rs 14.06 crore for the quarter ended December 31, 2025 as compared to Rs 7.62 crore in the same period l

  • Dr. Agarwals Health - Address Change

    3 Feb 2026, 8:00PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding change in Registered Office of the company.

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

    3 Feb 2026, 7:58PM Intimation of Change in Registered Office of the Company, is attached.

  • Dr. Agarwals Health - Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter And Nine Months

    3 Feb 2026, 7:53PM Consolidated and Standalone Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025, is attached.

  • Dr. Agarwals Health - Outcome of Board Meeting

    3 Feb 2026, 7:46PM Dr. Agarwal's Health Care Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Jan 2026, 8:34PM Intimation of Schedule of Analyst / Investors Meet, is attached.

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Jan 2026, 8:31PM Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Jan 2026, 6:17PM Intimation of Analyst / Earnings Conference call to discuss the Standalone And Consolidated Unaudited Financial Results of the Company For The Quarter

  • Dr. Agarwals Health - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financ

    28 Jan 2026, 6:11PM Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to cons

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Jan 2026, 6:07PM Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet

  • Dr. Agarwals Health has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    20 Jan 2026, 5:20PM As of December 2025, 32.39% is owned by Indian Promoters and 67.61% by Public. <p align=justify> Institutional holds 65.84% (Foreign Portfolio Investo

  • Dr. Agarwals Health - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    12 Jan 2026, 2:49PM Dr. Agarwal's Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Dr. Agarwals Health - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Jan 2026, 2:52PM As per the letter enclosed.

  • Dr. Agarwals Health - ESOP/ESOS/ESPS

    6 Jan 2026, 11:40AM Dr. Agarwal's Health Care Limited has informed the Exchange regarding Allotment of 337504 Equity Shares of INR 1 each upon exercise of 337504 options.

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    6 Jan 2026, 11:43AM As per the letter enclosed.

  • Dr. Agarwals Health - Trading Window

    26 Dec 2025, 7:12PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Reg

  • Dr. Agarwals Health - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    19 Dec 2025, 1:49PM The voting results in the prescribed format along with the Scrutinizer's Report on remote e-voting, for the Postal Ballot Notice dated November 12, 20

  • Dr. Agarwals Health - Shareholders meeting

    19 Dec 2025, 1:47PM The Voting Results in the prescribed format along with the Scrutinizer's Report on remote e-voting, for the Postal Ballot Notice dated November 12, 20

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    12 Dec 2025, 9:52PM As per the letter enclosed.

  • Dr. Agarwals Health - Allotment of Securities

    12 Dec 2025, 9:45PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding allotment of 299122 Equity shares of INR 1 each pursuant to ESOP/ESPS through ci
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Dr Agarwals Health Care Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 2078.86 1559.19 868.81 450.768
Liabilities 2078.86 1559.19 868.81 450.768
Equity 31.59 9.33 7.93 6.86
Gross Profit 245.1 221.1 159.28 84.5478
Net Profit 21.93 23.83 31.59 -1.4741
Cash From Operating Activities 208 221.58 152.69 78.2919
NPM(%) 2.1 2.85 5.28 -0.4
Revenue 1043.89 835.06 597.64 361.5898
Expenses 798.79 613.96 438.36 277.042
ROE(%) 1.13 1.23 1.63 -0.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dr Agarwals Health Care Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 725.70 0.24 43.09 254.83 301.39 0.69
Lotus Eye Hospital and Institute Ltd 117.51 -5.00 379.06 928.55 3.55 0.00
Vaishali Pharma Ltd 7.73 -0.64 0.00 5825.13 3.13 0.00
Astec Lifesciences Ltd 633.05 -0.99 0.00 875.65 -604.77 0.00

Company Info

Our Company was incorporated as `Dr. Agarwal's Health Care Limited' at Chennai, Tamil Nadu as a public limited company under the Companies Act, 1956, pursuant to the certificate of incorporation dated April 19, 2010, issued by the RoC and commenced operations pursuant to the certificate for commencement of business dated May 29, 2010, issued by the RoC.Major Events and Milestones:2010- Incorporation of our Company.- Entry into the Telangana (formerly a part of Andhra Pradesh) and Karnataka markets by entering into lease agreements for setting up eye clinics.2011- Investment by EILSF SPV 3 in our Company.2012- Entry into the Africa market by entering into an agreement with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique.2017- Entry into the Maharashtra market through the acquisition of hospital facilities in Maharashtra.2019- Investment by Claymore Investments (Mauritius) Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited and Value Growth Investment Holdings Pte. Ltd in our Company through subscription of equity shares.- Subscription of NCDs by British International Investment (formerly known as CDC Group PLC) in our Company.2021- Our Company launched its 100th eye care facility.2022- Investment by TPG Capital's Hyperion Investments Pte. Ltd. and Arvon Investments Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited in our Company through subscription of equity shares.- Entry into the Jammu market through the acquisition of Dr. Sood eye care practices from Dr. Rohan and Raj Deep Sood.- Strengthened presence in the Gujarat market through acquisition of the eye care business from Prizma Eyecare LLP, Dr. Sanjay Vallabhai Savani and Dr. Ashish P. Gusani2023- Strengthened presence in the Punjab market through the acquisition of Punjab Eye Hospital from Dr. Gurpal Singh2024- Entry in the Uttar Pradesh market through the acquisition of an eye care business in Varanasi.- Expanded our presence in Punjab market by acquisition of Dr Thind Eye Care Private Limited.

Our Company was incorporated as `Dr. Agarwal's Health Care Limited' at Chennai, Tamil Nadu as a public limited company under the Companies Act, 1956, pursuant to the certificate of incorporation dated April 19, 2010, issued by the RoC and commenced operations pursuant to the certificate for commencement of business dated May 29, 2010, issued by the RoC.Major Events and Milestones:2010- Incorporation of our Company.- Entry into the Telangana (formerly a part of Andhra Pradesh) and Karnataka markets by entering into lease agreements for setting up eye clinics.2011- Investment by EILSF SPV 3 in our Company.2012- Entry into the Africa market by entering into an agreement with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique.2017- Entry into the Maharashtra market through the acquisition of hospital facilities in Maharashtra.2019- Investment by Claymore Investments (Mauritius) Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited and Value Growth Investment Holdings Pte. Ltd in our Company through subscription of equity shares.- Subscription of NCDs by British International Investment (formerly known as CDC Group PLC) in our Company.2021- Our Company launched its 100th eye care facility.2022- Investment by TPG Capital's Hyperion Investments Pte. Ltd. and Arvon Investments Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited in our Company through subscription of equity shares.- Entry into the Jammu market through the acquisition of Dr. Sood eye care practices from Dr. Rohan and Raj Deep Sood.- Strengthened presence in the Gujarat market through acquisition of the eye care business from Prizma Eyecare LLP, Dr. Sanjay Vallabhai Savani and Dr. Ashish P. Gusani2023- Strengthened presence in the Punjab market through the acquisition of Punjab Eye Hospital from Dr. Gurpal Singh2024- Entry in the Uttar Pradesh market through the acquisition of an eye care business in Varanasi.- Expanded our presence in Punjab market by acquisition of Dr Thind Eye Care Private Limited.

Read More

Parent Organisation

Dr. Agarwals Health Care Ltd.

Founded

19/04/2010

Managing Director

Dr.Adil Agarwal

NSE Symbol

AGARWALEYEEQ

FAQ

The current price of Dr Agarwals Health Care Ltd is ₹ 445.90.

The 52-week high for Dr Agarwals Health Care Ltd is ₹ 451.80 and the 52-week low is ₹ 442.95.

The market capitalization of Dr Agarwals Health Care Ltd is currently ₹ 14126.45. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dr Agarwals Health Care Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dr Agarwals Health Care Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dr Agarwals Health Care Ltd shares.

The CEO of Dr Agarwals Health Care Ltd is Dr.Adil Agarwal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT